Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jan-Feb;34(1):12-7.
doi: 10.5144/0256-4947.2014.12.

The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis

Affiliations
Meta-Analysis

The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis

Ying Liu et al. Ann Saudi Med. 2014 Jan-Feb.

Abstract

Background and objectives: Many studies were conducted to assess the relationship between Monoamine oxidase B (MAOB) A644G polymorphism and susceptibility to Parkinson disease (PD). However, the results were inconsistent and inconclusive.

Design and settings: A meta-analysis was conducted from all published studies on the associations between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease.

Methods: In this present study, the possible relationship between MAOB A644G polymorphism and PD risk was assessed by a meta-analysis. Eligible articles were identified for the period up to March 2013. Pooled odds ratios (OR) with 95% confidence intervals (CI) were appropriately derived from fixed-effects models.

Results: Twenty case-control studies with a total of 2846 cases and 3508 controls were eligible. In a recessive model, MAOB A644G polymorphism was associated with PD risk (OR=1.32, 95% CI 1.18-1.47, P < .001). Subgroup analyses by ethnicity and gender also found significant relationships between this polymorphism and PD risk.

Conclusion: This meta-analysis suggested that MAOB A644G polymorphism may be associated with PD development.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of study identification, inclusion, and exclusion.
Figure 2
Figure 2
Meta-analysis for the relationship between the MAOB A644G polymorphism and PD risk.
Figure 3
Figure 3
Cumulative meta-analysis of relationship between the MAOB A644G polymorphism and PD risk.
Figure 4
Figure 4
Sensitivity analysis for the MAOB A644G polymorphism and PD risk.
Figure 5
Figure 5
Funnel plot for publication bias test in the meta-analysis investigating the relationship between the MAOB A644G polymorphism and PD risk.

Similar articles

Cited by

References

    1. Fritsch T, Smyth KA, Wallendal MS, Hyde T, Leo G, Geldmacher DS. Parkinson Disease: Research Update and Clinical Management. South Med J. 2012;105:650–6. - PubMed
    1. Zimprich A. Genetics of Parkinson’s disease and essential tremor. Curr Opin Neurol. 2011;24:318–23. - PubMed
    1. Langston JW. Epidemiology versus genetics in Parkinson’s disease: progress in resolving an age-old debate. Ann Neurol. 1998;44:S45–S52. - PubMed
    1. Steventon G, Sturman S, Heafield M, Waring R, Napier J, Williams A. Platelet monoamine oxidase-B activity in Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1989;1:255–61. - PubMed
    1. Kumar MJ, Andersen JK. Perspectives on MAO-B in aging and neurological disease: Where do we go from here? Mol Neurobiol. 2004;30:77–89. - PubMed

Publication types

Substances

LinkOut - more resources